Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P06239 (LCK_HUMAN) Homo sapiens (Human)

Tyrosine-protein kinase Lck UniProtKBInterProSTRINGInteractive Modelling

509 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3); 4 identical sequences: Homo sapiens: A0A0S2Z3Y8; Pan troglodytes: A0A2J8IYW7; Pan paniscus: A0A2R9AKH9; Gorilla gorilla gorilla: G3QJD4

Available Structures

57 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PH… Heteromer
63-509
Assess
Crystal Structure of Lck SH2-SH3 with SH2 binding site of p130Cas Heteromer
Q63767;
64-226
NA;
Assess
Monobody Mb(Lck_3) bound to Lck-SH2 domain Heteromer
119-226
ZN;
Assess
SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOT… Heteromer
P03079;
123-226
Assess
FREE P56LCK SH2 DOMAIN Heteromer
123-226
Assess
Monobody Mb(Lck_1) bound to Lck-Sh2 Heteromer
121-210
SO4;
Assess
Solution structure of T-cell surface glycoprotein CD4 and Proto-oncogene tyrosine-protein kinase LC… Heteromer
P01730;
7-35
ZN;
Assess
Solution structure of T-cell surface glycoprotein CD8 alpha chain and Proto-oncogene tyrosine-prote… Heteromer
P01732;
7-35
ZN;
Assess
Protein Tyrosine Phosphatase PTPN-22 (Lyp) bound to the mono-Phosphorylated Lck active site peptide Heteromer
Q9Y2R2;
391-397
PO4;
Assess
Crystal structure of UNC119 in complex with LCK peptide Heteromer
Q13432;
2-7
GOL;15P;MYR;
Assess
crystal structure of aminoquinazoline 1 bound to Lckhomo-2-mer232-498
242;
Assess
HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDEhomo-2-mer127-222
Assess
SH3 Domain of Human Lckhomo-2-mer59-119
ZN;CA;PG4;
Assess
Tyrosine-protein kinase LCK bound to Compound 11monomer225-500
ODJ;CXS;SO4;NI;
Assess
Crystal structure of Triazolone derivative bound to the kinase domain of human LCK, (auto-phosphory…monomer230-502
SO4;DMS;MPD;5PB;
Assess
x-ray crystal structure of 2-aminopyrimidine carbamate 43 bound to Lckmonomer229-501
SO4;1N9;
Assess
Crystal structure of Pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-…monomer230-502
SO4;DMS;KSC;
Assess
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM…monomer231-502
SO4;ANP;EDO;
Assess
Crystal structure of pyrazin derivative bound to the kinase domain of Human LCK, (Auto-phosphorylat…monomer231-502
SO4;DMS;MPD;KZI;
Assess
X-ray co-crystal structure aminobenzimidazole triazine 1 bound to Lckmonomer230-501
SO4;AM0;
Assess
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM…monomer231-502
SO4;STU;
Assess
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-…monomer231-502
SO4;DMS;MPD;KSE;
Assess
Crystal structure of imidazo pyrimidine derivative bound to the kinase domain of human LCK, (Auto-p…monomer231-502
SO4;DMS;KSS;
Assess
co-crystal structure of Lck and aminopyrimidine amide 10bmonomer230-501
AM5;
Assess
Crystal Structure of Methoxy Benzofuran Derivative bound to the Kinase domain of human LCK, (auto-p…monomer231-502
SO4;DMS;MPD;KBM;
Assess
Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-…monomer231-502
SO4;DMS;KZM;
Assess
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-…monomer231-502
SO4;KSH;
Assess
Crystal structure of Pyrrolo pyrazine derivative bound to the kinase domain of human LCK, (auto-pho…monomer231-502
SO4;DMS;KSR;
Assess
Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-…monomer231-502
SO4;DMS;KZL;
Assess
THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)monomer231-501
SO4;
Assess
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM…monomer231-501
SO4;PP2;
Assess
crystal structure of furanopyrimidine 8 bound to lckmonomer231-501
547;
Assess
X-Ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-…monomer231-501
SO4;AM9;
Assess
Crystal structure of imidazo pyrazin 1 bound to the kinase domain of human LCK, (auto-phosphorylate…monomer231-501
SO4;DMS;KSF;
Assess
co-crystal structure of Lck and aminopyrimidine reverse amide 23monomer231-501
AM6;
Assess
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-…monomer231-501
SO4;KSK;
Assess
Crystal structure of phenylimidazo pyrazin 2 bound to the kinase domain of human LCK, (auto-phospho…monomer231-501
SO4;KSL;
Assess
crystal structure of furanopyrimidine 1 bound to lckmonomer231-501
979;
Assess
Crystal structure of imidazo quinoxaline 1 bound to the kinase domain of human LCK, activated form …monomer231-501
SO4;DMS;KSM;
Assess
Structure of human LCK kinase with a small molecule inhibitormonomer231-501
LHL;SO4;
Assess
LCK bound to imatinibmonomer231-498
STI;
Assess
CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE.monomer236-501
SO4;STU;
Assess
The complex crystal structure of LCK with a probe molecule w259monomer238-501
SO4;CA;925;
Assess
Crystal structure of pyrimidine amide 11 bound to Lckmonomer238-500
9NH;
Assess
crystal structure of aminoquinazoline 36 bound to Lckmonomer237-499
1N8;
Assess
Structure of Lck in complex with a compound discovered by Virtual Fragment Linkingmonomer238-498
7KW;
Assess
LCK complexed with a pyrazolopyrimidinemonomer238-498
5LK;EDO;
Assess
Crystal structure of a SH3-SH2 domains of a lymphocyte-specific protein tyrosine kinase (LCK) from …monomer64-226
SO4;GOL;
Assess
HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU…monomer122-226
ACE;
Assess
P56LCK SH2 DOMAIN INHIBITOR COMPLEXmonomer122-226
Assess
HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU…monomer123-226
Assess
Crystal structure of LCK SH2 complexed with nonpeptide phosphotyrosine mimeticmonomer123-226
CC0;
Assess
Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor with in vivo …monomer123-226
CC1;
Assess
The Crystal Structure of LCK from Biortus.monomer125-226
CL;EDO;PG4;
Assess
HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDEmonomer127-222
Assess
SH3 domain of human Lck tyrosine kinasemonomer58-120
Assess
SH3 Domain of Lymphocyte Specific Kinase (LCK)monomer64-120
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1y57.1.Amonomer0.7964-507
60.59
Assess
2h8h.1.Amonomer0.7867-507
60.44
Assess
1opl.2.Amonomer0.75121-500
43.06
Assess
8gmb.1.Amonomer0.7161-500
35.85
Assess

10 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21lck.1.Amonomer0.7863-226
GLU;100.00
Assess
Isoform 21y57.1.Amonomer0.7363-356
52.04
Assess
Isoform 22h8h.1.Amonomer0.7165-356
51.86
Assess
Isoform 24fl2.1.Amonomer0.64120-356
33.19
Assess
Isoform 21opl.2.Amonomer0.64121-348
42.91
Assess
Isoform 28gmb.1.Amonomer0.6361-354
36.21
Assess
Isoform 31y57.1.Amonomer0.7364-537
60.36
Assess
Isoform 33vs3.2.Amonomer0.7365-539
VSE;72.13
Assess
Isoform 31opl.2.Amonomer0.70121-530
43.06
Assess
Isoform 38gmb.1.Amonomer0.6661-530
35.64
Assess